Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SCM06
- Development stage
- Unknown
- Lead developer
- GenieBiome
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
SCM06 is a synbiotic probiotic formulation developed by GenieBiome (G-NiiB), a biotechnology company spun off from The Chinese University of Hong Kong. Designed specifically for pediatric wellness, the formula utilizes a proprietary "3+3" approach, combining three specific strains of beneficial bacteria (probiotics) with three types of prebiotics (selective fibers) to optimize the gut microbiome. The product is intended to support the development of a healthy immune system in children and is frequently marketed for the management of skin sensitivity and atopic conditions such as eczema. By restoring microbial balance in the gut, SCM06 aims to reduce systemic inflammation and improve overall health outcomes in the pediatric population.
- Brand names
- G-NiiB Microbiome Children Wellness FormulaG-NiiB 微生態兒童恬悅配方
- Other names
- Microbiome Children Wellness FormulaG-NiiB Kids Wellness
Beyond the preview
Go deeper on SCM06.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SCM06.